BMS-247550 in Treating Patients With Advanced Cancers
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effectiveness of BMS-247550 in treating patients who have
malignant solid tumors or lymphoma. Drugs used in chemotherapy use different ways to stop
tumor cells from dividing so they stop growing or die.